(Q77849792)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360908%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360908%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

W H Kutteh

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360908%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

V M Park

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360908%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S R Deitcher

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360908%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360908%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360908%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360908%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360908%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1048-1053

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360908%20AND%20SRC:MED&resulttype=core&format=json

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

World distribution of factor V Leiden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Factor V Leiden mutation as a risk factor for recurrent pregnancy loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Mutation in blood coagulation factor V associated with resistance to activated protein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

The factor V Leiden mutation is not a common cause of recurrent miscarriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Increased fetal loss in women with heritable thrombophilia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Second-trimester pregnancy loss is associated with activated C resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Changes in activated protein C resistance during normal pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

A woman with five consecutive fetal deaths: Case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8

Factor V Leiden and its relevance in patients with recurrent abortions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900133-8